These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37976795)

  • 1. Relative anemia and perioperative stroke in children with moyamoya.
    Gatti JR; Ahmad SA; Gardner Yelton S; DiGiusto M; Leung D; Xu R; Cohen AR; Gottesman RF; Sun LR
    J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107476. PubMed ID: 37976795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Moyamoya Revascularization Perioperative Care: A Modified Delphi Study.
    Sun LR; Jordan LC; Smith ER; Aldana PR; Kirschen MP; Guilliams K; Gupta N; Steinberg GK; Fox C; Harrar DB; Lee S; Chung MG; Dirks P; Dlamini N; Maher CO; Lehman LL; Hong SJ; Strahle JM; Pineda JA; Beslow LA; Rasmussen L; Mailo J; Piatt J; Lang SS; Adelson PD; Dewan MC; Mineyko A; McClugage S; Vadivelu S; Dowling MM; Hersh DS
    Neurocrit Care; 2024 Apr; 40(2):587-602. PubMed ID: 37470933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER; McClain CD; Heeney M; Scott RM
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors and Imaging Biomarkers Associated With Perioperative Stroke in Pediatric Moyamoya Arteriopathy.
    Gardner Yelton SE; Gatti J; Adil M; Guryildirim M; Tekes A; Sun LR
    J Child Neurol; 2022 Dec; 37(12-14):963-969. PubMed ID: 36128779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
    Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
    J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of postoperative stroke in pediatric moyamoya patients: a standardized perioperative care protocol.
    Judge J; Kappel AD; Isibor C; O'Hara JE; Larson A; Kleinman M; See AP; Lehman LL; Smith ER
    J Neurosurg Pediatr; 2024 Feb; 33(2):185-189. PubMed ID: 37976515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of Revascularization in Ischemic Moyamoya Disease: Association of Early Versus Delayed Surgery with Perioperative and Long-Term Outcomes.
    Xu R; Xie ME; Khalifeh J; Feghali J; Yang W; Kim J; Liew J; Tamargo RJ; Huang J
    World Neurosurg; 2022 Oct; 166():e721-e730. PubMed ID: 35931338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of antiplatelet therapy during the perioperative period of revascularization surgery for moyamoya disease patients with ischemic onset.
    Nakamura A; Takasu S; Seki Y; Saito R
    Nagoya J Med Sci; 2024 Feb; 86(1):82-90. PubMed ID: 38505724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice variability in the perioperative management of pediatric moyamoya disease in North America.
    Sun LR; Hersh DS; Smith ER; Aldana PR; Jordan LC
    J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107029. PubMed ID: 36706654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to reduce the complication rate of multiple burr holes surgery in moyamoya angiopathy.
    Soler-Rico M; Di Santo M; Vaz G; Joris V; Fomekong E; Guillaume S; Van Boven M; Raftopoulos C
    Acta Neurochir (Wien); 2023 Dec; 165(12):3613-3622. PubMed ID: 37993630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ischemic complications following surgical treatment of moyamoya disease: risk factors and prevention].
    Lukshin VA; Shulgina AA; Usachev DY; Korshunov AE; Belousova OB; Lubnin AY
    Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(6):26-35. PubMed ID: 34951757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series.
    Morshed RA; Abla AA; Murph D; Dao JM; Winkler EA; Burkhardt JK; Colao K; Hetts SW; Fullerton HJ; Lawton MT; Gupta N; Fox CK
    J Clin Neurosci; 2020 Sep; 79():137-143. PubMed ID: 33070883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review.
    Newman S; Boulter JH; Malcolm JG; Pradilla I; Pradilla G
    World Neurosurg; 2020 Mar; 135():165-170. PubMed ID: 31790841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential Role of Preoperative Posterior Cerebral Artery Involvement in Predicting Postoperative Transient Neurological Deficits and Ischemic Stroke After Indirect Revascularization in Patients With Moyamoya Disease.
    Araki Y; Yokoyama K; Uda K; Kanamori F; Takayanagi K; Ishii K; Nishihori M; Goto S; Tsukada T; Takeuchi K; Tanahashi K; Nagata Y; Nishimura Y; Tanei T; Nagashima Y; Muraoka S; Izumi T; Seki Y; Saito R
    World Neurosurg; 2024 Jul; 187():e610-e619. PubMed ID: 38677649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
    Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
    World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient ischemic attack after indirect revascularization surgery for pediatric patients with moyamoya disease: A retrospective study of intraoperative blood pressure.
    Zhu B; He L
    Anaesth Crit Care Pain Med; 2023 Feb; 42(1):101168. PubMed ID: 36309164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of Quantitative Cerebral Blood Flow Measurement in the Acute Stage after Revascularization Surgery for Adult Moyamoya Disease: Implication for the Pathological Threshold of Local Cerebral Hyperperfusion.
    Kameyama M; Fujimura M; Tashiro R; Sato K; Endo H; Niizuma K; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2019; 48(3-6):217-225. PubMed ID: 31812964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Ischemic Stroke After Revascularization Surgery in Patients with Moyamoya Disease: An Age-Stratified Comparative Meta-Analysis.
    Pettersson SD; Olofsson HKL; Ali S; Szarek D; Miękisiak G; Ogilvy CS
    World Neurosurg; 2023 May; 173():146-157.e14. PubMed ID: 36716854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.